FIELD: medicine.
SUBSTANCE: method involves determining lactate, pyruvic acid concentration, superoxide dismutase activity in patient saliva sample. Lactate concentration increase being equal to or and higher than 50%, pyruvic acid concentration drop being equal to or greater than 60% and superoxide dismutase activity being equal to or and higher than 50% when compared to norm, neurocirculatory dystonia diagnosis is to be set.
EFFECT: simplified noninvasive diagnosis method in preclinical stage cases.
Title | Year | Author | Number |
---|---|---|---|
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR ARTERIAL HYPERTENSION AND HYPERTENSIVE NEUROCIRCULATORY DYSTONIA IN ADOLESCENTS | 2010 |
|
RU2429485C1 |
DIAGNOSTIC TECHNIQUE FOR ARTERIAL HYPERTENSION IN ADOLESCENTS | 2010 |
|
RU2419799C1 |
METHOD OF DIFFERENTIAL DIAGNOSTICS OF ARTERIAL HYPERTENSION AND NEUROCIRCULATORY DISTONIA OF HYPERTONIC TYPE IN TEENAGERS | 2010 |
|
RU2439574C1 |
METHOD FOR SELECTING ADOLESCENTS TO RISK GROUP OF DEVELOPING ARTERIAL HYPERTENSION | 2013 |
|
RU2528901C1 |
METHOD FOR EVALUATING HYPOXIA COMPENSATION CONDITION IN MITRAL VALVE PROLAPSE CASES | 2004 |
|
RU2277245C1 |
DIAGNOSTIC TECHNIQUE FOR STAGE THREE ALCOHOLISM | 2010 |
|
RU2450269C2 |
METHOD FOR DETERMINING TREATMENT EFFECTIVENESS IN PATIENTS PRIMARY BICUSPID VALVE PROLAPSE USING MAGNESIUM-CONTAINING PREPARATIONS | 2004 |
|
RU2278387C2 |
METHOD OF DIAGNOSIS OF PYELONEPHRITIS ACUTE STAGE | 1994 |
|
RU2115124C1 |
METHOD FOR ESTIMATING EFFICACY OF THERAPY OF PRIMARY HYPERTENSION | 2009 |
|
RU2412653C1 |
METHOD FOR DESCRIBING INDICATIONS FOR CHOOSING CONSERVATIVE THERAPEUTIC APPROACH TO PATIENTS SUFFERED RECURRENT MYOCARDIAL INFARCTION | 2012 |
|
RU2487353C1 |
Authors
Dates
2006-04-20—Published
2005-04-18—Filed